Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
28.4M
-
Shares change
-
-186K
-
Total reported value, excl. options
-
$63.5M
-
Value change
-
-$455K
-
Put/Call ratio
-
2.91
-
Number of buys
-
39
-
Number of sells
-
-22
-
Price
-
$2.24
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q2 2020
81 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q2 2020.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.4M shares
of 52.3M outstanding shares and own 54.26% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.62M shares), BlackRock Inc. (3.56M shares), RENAISSANCE TECHNOLOGIES LLC (3.47M shares), Evermore Global Advisors, LLC (3.22M shares), VANGUARD GROUP INC (2.39M shares), DIMENSIONAL FUND ADVISORS LP (1.96M shares), WELLINGTON MANAGEMENT GROUP LLP (1.07M shares), STATE STREET CORP (806K shares), ARIEL INVESTMENTS, LLC (659K shares), and Roumell Asset Management, LLC (612K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.